A Study of SA-001 to Treat Pancreatic Exocrine Insufficiency
A Double-blind, Placebo-controlled, Parallel-group, Comparative Study to Confirm the Safety and Efficacy of Oral 1.5 g/Day and 3.0 g/Day of SA-001 in Patients With Pancreatic Exocrine Insufficiency Caused by Chronic Pancreatitis or by Pancreatectomy
1 other identifier
interventional
274
1 country
98
Brief Summary
This study is to verify the efficacy of 3.0 g/day of SA-001 in patients with pancreatic exocrine insufficiency caused by chronic pancreatitis in the non-compensatory stage or by pancreatectomy as compared with placebo under a double-blind design using the change in a coefficient of fat absorption as a primary endpoint.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3
Started May 2007
98 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 16, 2006
CompletedFirst Posted
Study publicly available on registry
November 17, 2006
CompletedStudy Start
First participant enrolled
May 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2009
CompletedJuly 28, 2011
July 1, 2011
2.3 years
November 16, 2006
July 27, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in CFA from baseline to the end of double-blind treatment
7 days after baseline
Secondary Outcomes (1)
Stool fat excretion, stool weight, stool frequency, nutritional parameters
7 days after baseline
Study Arms (3)
L
EXPERIMENTALH
EXPERIMENTALP
PLACEBO COMPARATORInterventions
Eligibility Criteria
You may qualify if:
- Subjects with chronic pancreatitis in the non-compensatory stage or pancreatectomy
- Subjects whose CFA is 80% or less
- Subjects who are able to be hospitalized
You may not qualify if:
- Subjects who are judged to be difficult to have at least 40 g/day of fat intake during course of the study
- Subjects who have a known allergy to porcine protein and/or any component of digestive enzyme preparations
- Subjects who are in the acute phase of chronic pancreatitis
- Subjects with non-pancreatic malabsorption syndrome
- Subjects with acute pancreatitis or ileus
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Abbottlead
Study Sites (98)
Site Reference ID/Investigator# 59845
Aichi, Japan
Site Reference ID/Investigator# 59933
Aichi, Japan
Site Reference ID/Investigator# 59928
Akita, Japan
Site Reference ID/Investigator# 59983
Amori, Japan
Site Reference ID/Investigator# 59984
Amori, Japan
Site Reference ID/Investigator# 59569
Ehime, Japan
Site Reference ID/Investigator# 59938
Ehime, Japan
Site Reference ID/Investigator# 59571
Fukuoka, Japan
Site Reference ID/Investigator# 59572
Fukuoka, Japan
Site Reference ID/Investigator# 59812
Fukuoka, Japan
Site Reference ID/Investigator# 59826
Fukuoka, Japan
Site Reference ID/Investigator# 59848
Fukuoka, Japan
Site Reference ID/Investigator# 59922
Fukuoka, Japan
Site Reference ID/Investigator# 59923
Fukuoka, Japan
Site Reference ID/Investigator# 59980
Fukuoka, Japan
Site Reference ID/Investigator# 59932
Fukushima, Japan
Site Reference ID/Investigator# 59935
Fukushima, Japan
Site Reference ID/Investigator# 59930
Higashiibaraki, Japan
Site Reference ID/Investigator# 59929
Hiroshima, Japan
Site Reference ID/Investigator# 59968
Hiroshima, Japan
Site Reference ID/Investigator# 59972
Hiroshima, Japan
Site Reference ID/Investigator# 59827
Hokkaido, Japan
Site Reference ID/Investigator# 59939
Hokkaido, Japan
Site Reference ID/Investigator# 59969
Hokkaido, Japan
Site Reference ID/Investigator# 59974
Hokkaido, Japan
Site Reference ID/Investigator# 59981
Hokkaido, Japan
Site Reference ID/Investigator# 59982
Hokkaido, Japan
Site Reference ID/Investigator# 59576
Hyōgo, Japan
Site Reference ID/Investigator# 59830
Hyōgo, Japan
Site Reference ID/Investigator# 59847
Hyōgo, Japan
Site Reference ID/Investigator# 59907
Hyōgo, Japan
Site Reference ID/Investigator# 59908
Hyōgo, Japan
Site Reference ID/Investigator# 59566
Ishikawa, Japan
Site Reference ID/Investigator# 59911
Ishikawa, Japan
Site Reference ID/Investigator# 59931
Kagoshima, Japan
Site Reference ID/Investigator# 59564
Kanagawa, Japan
Site Reference ID/Investigator# 59565
Kanagawa, Japan
Site Reference ID/Investigator# 59819
Kanagawa, Japan
Site Reference ID/Investigator# 59820
Kanagawa, Japan
Site Reference ID/Investigator# 59823
Kanagawa, Japan
Site Reference ID/Investigator# 59844
Kanagawa, Japan
Site Reference ID/Investigator# 59858
Kanagawa, Japan
Site Reference ID/Investigator# 59570
Kouchi, Japan
Site Reference ID/Investigator# 59574
Kumamoto, Japan
Site Reference ID/Investigator# 59854
Kurihara, Japan
Site Reference ID/Investigator# 59821
Kyoto, Japan
Site Reference ID/Investigator# 59910
Mie, Japan
Site Reference ID/Investigator# 59979
Mie, Japan
Site Reference ID/Investigator# 59849
Miyagi, Japan
Site Reference ID/Investigator# 59851
Miyagi, Japan
Site Reference ID/Investigator# 59857
Miyagi, Japan
Site Reference ID/Investigator# 59975
Miyagi, Japan
Site Reference ID/Investigator# 59976
Miyagi, Japan
Site Reference ID/Investigator# 59977
Miyagi, Japan
Site Reference ID/Investigator# 59937
Miyazaki, Japan
Site Reference ID/Investigator# 59913
Nagano, Japan
Site Reference ID/Investigator# 59825
Nagasaki, Japan
Site Reference ID/Investigator# 59814
Nagoya, Japan
Site Reference ID/Investigator# 59936
Nagoya, Japan
Site Reference ID/Investigator# 59927
Nara, Japan
Site Reference ID/Investigator# 59577
Okayama, Japan
Site Reference ID/Investigator# 59567
Osaka, Japan
Site Reference ID/Investigator# 59568
Osaka, Japan
Site Reference ID/Investigator# 59575
Osaka, Japan
Site Reference ID/Investigator# 59815
Osaka, Japan
Site Reference ID/Investigator# 59822
Osaka, Japan
Site Reference ID/Investigator# 59824
Osaka, Japan
Site Reference ID/Investigator# 59829
Osaka, Japan
Site Reference ID/Investigator# 59912
Osaka, Japan
Site Reference ID/Investigator# 59914
Osaka, Japan
Site Reference ID/Investigator# 59915
Osaka, Japan
Site Reference ID/Investigator# 59934
Osaka, Japan
Site Reference ID/Investigator# 59940
Osaka, Japan
Site Reference ID/Investigator# 59573
Saga, Japan
Site Reference ID/Investigator# 59556
Saitama, Japan
Site Reference ID/Investigator# 59925
Saitama, Japan
Site Reference ID/Investigator# 59555
Sapporo, Japan
Site Reference ID/Investigator# 59810
Shiga, Japan
Site Reference ID/Investigator# 59852
Shimane, Japan
Site Reference ID/Investigator# 59855
Suwa, Japan
Site Reference ID/Investigator# 59909
Tochigi, Japan
Site Reference ID/Investigator# 59557
Tokyo, Japan
Site Reference ID/Investigator# 59813
Tokyo, Japan
Site Reference ID/Investigator# 59818
Tokyo, Japan
Site Reference ID/Investigator# 59850
Tokyo, Japan
Site Reference ID/Investigator# 59859
Tokyo, Japan
Site Reference ID/Investigator# 59971
Tokyo, Japan
Site Reference ID/Investigator# 59973
Tokyo, Japan
Site Reference ID/Investigator# 59978
Tokyo, Japan
Site Reference ID/Investigator# 59816
Toyama, Japan
Site Reference ID/Investigator# 59970
Toyama, Japan
Site Reference ID/Investigator# 59811
Wakayama, Japan
Site Reference ID/Investigator# 59856
Yamagata, Japan
Site Reference ID/Investigator# 59926
Yamagata, Japan
Site Reference ID/Investigator# 59817
Yamaguchi, Japan
Site Reference ID/Investigator# 59924
Yamaguchi, Japan
Site Reference ID/Investigator# 59846
Yamanashi, Japan
Site Reference ID/Investigator# 59828
Yokohama, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Toshiaki Yamaguchi, BS Pharm
Abbott
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 16, 2006
First Posted
November 17, 2006
Study Start
May 1, 2007
Primary Completion
August 1, 2009
Study Completion
August 1, 2009
Last Updated
July 28, 2011
Record last verified: 2011-07